{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:56:28Z","timestamp":1781182588806,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014069","name":"Funda\u00e7\u00e3o Champalimaud","doi-asserted-by":"publisher","award":["2020.4875"],"award-info":[{"award-number":["2020.4875"]}],"id":[{"id":"10.13039\/501100014069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["PTDC\/MED-ONC\/1215\/2021\/PT"],"award-info":[{"award-number":["PTDC\/MED-ONC\/1215\/2021\/PT"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tranon.2025.102643","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:57:26Z","timestamp":1766141846000},"page":"102643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["BioMarrow: An accessible and reproducible 3D patient-derived bone marrow model for advancing research and clinical applications"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-1398","authenticated-orcid":false,"given":"Diana","family":"Louren\u00e7o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-6192","authenticated-orcid":false,"given":"Raquel","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7509-9066","authenticated-orcid":false,"given":"Joana","family":"Caetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Barahona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Queir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5235-6557","authenticated-orcid":false,"given":"Emilie Arnault","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3978-766X","authenticated-orcid":false,"given":"Cristina","family":"Jo\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2025.102643_bib0001","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management","volume":"99","author":"Rajkumar","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.tranon.2025.102643_bib0002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41408-025-01264-2","article-title":"Venetoclax-based treatment combinations in relapsed\/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes","volume":"15","author":"Bolarinwa","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.tranon.2025.102643_bib0003","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41408-024-01139-y","article-title":"Bispecific antibodies in the treatment of multiple myeloma","volume":"14","author":"Devasia","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.tranon.2025.102643_bib0004","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood.2025028330","article-title":"Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST","volume":"146","author":"Merz","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2025.102643_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2025.101385","article-title":"Trends over 48 years in a one-number index of survival for all cancers combined, England and Wales (1971\u20132018): a population-based registry study","volume":"56","author":"Coleman","year":"2025","journal-title":"The Lancet Regional Health \u2013 Europe"},{"key":"10.1016\/j.tranon.2025.102643_bib0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2025.102643_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112888","article-title":"Patient-derived multiple myeloma 3D models for personalized medicine\u2014Are we there yet?","volume":"23","author":"Louren\u00e7o","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2025.102643_bib0008","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s43018-023-00544-9","article-title":"Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma","volume":"4","author":"Kropivsek","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tranon.2025.102643_bib0009","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/1878-0261.13191","article-title":"Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically","volume":"16","author":"Giliberto","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.tranon.2025.102643_bib0010","article-title":"High-throughput drug screening and multi-omic analysis to guide individualized treatment for multiple myeloma","volume":"5","author":"Coffey","year":"2021","journal-title":"JCo Precis. Oncol."},{"key":"10.1016\/j.tranon.2025.102643_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98760-9","article-title":"A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma","volume":"11","author":"Alhallak","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2025.102643_bib0012","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood-2008-02-142430","article-title":"A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma","volume":"112","author":"Kirshner","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2025.102643_bib0013","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0301-472X(03)00023-7","article-title":"Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells","volume":"31","author":"Greenstein","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.tranon.2025.102643_bib0014","doi-asserted-by":"crossref","DOI":"10.3791\/50947-v","article-title":"A three-dimensional tissue culture model to study primary human bone marrow and its malignancies","author":"Parikh","year":"2014","journal-title":"J. Vis. Exp. JoVE"},{"key":"10.1016\/j.tranon.2025.102643_bib0015","author":"Celgene"},{"key":"10.1016\/j.tranon.2025.102643_bib0016","first-page":"76","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"1","author":"Ria","year":"2011","journal-title":"Am. J. Blood Res."},{"key":"10.1016\/j.tranon.2025.102643_bib0017","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1038\/s41467-020-19932-1","article-title":"Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma","volume":"11","author":"Federico","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2025.102643_bib0018","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood.V85.4.997.bloodjournal854997","article-title":"Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6\/E7 genes","volume":"85","author":"Roecklein","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2025.102643_bib0019","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drudis.2012.10.003","article-title":"Three-dimensional cell culture: the missing link in drug discovery","volume":"18","author":"Breslin","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tranon.2025.102643_bib0020","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.semcancer.2005.05.004","article-title":"Matrigel: basement membrane matrix with biological activity","volume":"15","author":"Kleinman","year":"2005","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tranon.2025.102643_bib0021","doi-asserted-by":"crossref","first-page":"bpab014","DOI":"10.1093\/biomethods\/bpab014","article-title":"Quantifying the invasion and migration ability of cancer cells with a 3D Matrigel drop invasion assay","volume":"6","author":"Aslan","year":"2021","journal-title":"Biol. Methods Protoc."},{"key":"10.1016\/j.tranon.2025.102643_bib0022","article-title":"Basement membrane properties and their recapitulation in organ-on-chip applications","volume":"15","author":"Salimbeigi","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.tranon.2025.102643_bib0023","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.chroma.2015.03.080","article-title":"Transient conformational modification of immunoglobulin G during purification by protein A affinity chromatography","volume":"1395","author":"Gagnon","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tranon.2025.102643_bib0024","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1529\/biophysj.104.050682","article-title":"Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration","volume":"89","author":"Raeber","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.tranon.2025.102643_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41536-020-00116-w","article-title":"Self-assembling peptide scaffolds in the clinic","volume":"6","author":"Gelain","year":"2021","journal-title":"NPJ. Regen. Med."},{"key":"10.1016\/j.tranon.2025.102643_bib0026","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2184.2001.00222.x","article-title":"Human red blood cells have an enhancing effect on the relative expansion of CD8+ T lymphocytes in vitro","volume":"34","author":"Porto","year":"2001","journal-title":"Cell Prolif."},{"key":"10.1016\/j.tranon.2025.102643_bib0027","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1186\/s13287-021-02610-4","article-title":"Red blood cells and their releasates compromise bone marrow-derived human mesenchymal stem\/stromal cell survival in vitro","volume":"12","author":"Dregalla","year":"2021","journal-title":"Stem Cell Res. Therapy"},{"key":"10.1016\/j.tranon.2025.102643_bib0028","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1182\/blood-2014-02-558007","article-title":"Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model","volume":"124","author":"Reagan","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2025.102643_bib0029","first-page":"1933","article-title":"Physiological migration of hematopoietic stem and progenitor cells","volume":"294","author":"Wright","year":"2001","journal-title":"Science (1979)"},{"key":"10.1016\/j.tranon.2025.102643_bib0030","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.3390\/cancers12123643","article-title":"Tumour dissemination in multiple myeloma disease progression and relapse: a potential therapeutic target in high-risk myeloma","volume":"12","author":"Zeissig","year":"2020","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.tranon.2025.102643_bib0031","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.3390\/jcm11216491","article-title":"Pathways of angiogenic and inflammatory cytokines in multiple myeloma: role in plasma cell clonal expansion and drug resistance","volume":"11","author":"Melaccio","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tranon.2025.102643_bib0032","doi-asserted-by":"crossref","first-page":"77326","DOI":"10.18632\/oncotarget.12643","article-title":"A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications","volume":"7","author":"Jakubikova","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.tranon.2025.102643_bib0033","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2478\/v10042-009-0015-1","article-title":"A comparison of cytokine production in 2-dimensional and 3-dimensional cultures of bone marrow stromal cells of muliple myeloma patients in response to RPMI8226 myeloma cells","volume":"47","author":"Zdzisi\u0144ska","year":"2009","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.tranon.2025.102643_bib0034","article-title":"Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma, front","volume":"9","author":"Harmer","year":"2019","journal-title":"Endocrinol."},{"key":"10.1016\/j.tranon.2025.102643_bib0035","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.V87.5.1928.1928","article-title":"Transforming growth factor-\u03b21: differential effects on multiple myeloma versus normal B cells","volume":"87","author":"Urashima","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2025.102643_bib0036","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41375-024-02391-8","article-title":"IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma","volume":"38","author":"Sun","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.tranon.2025.102643_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003975","article-title":"Tumor-associated macrophages in multiple myeloma: advances in biology and therapy","volume":"10","author":"Sun","year":"2022","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.tranon.2025.102643_bib0038","first-page":"997","volume":"14","author":"Cai","year":"2025","journal-title":"T Cells Dysfunction in Multiple Myeloma, ITT Volume"},{"key":"10.1016\/j.tranon.2025.102643_bib0039","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.leukres.2009.01.020","article-title":"Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group","volume":"33","author":"Lacy","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.tranon.2025.102643_bib0040","first-page":"357","article-title":"The Rho kinase inhibitor fasudil augments the number of functional endothelial progenitor cells in ex vivo cultures","volume":"28","author":"E","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.tranon.2025.102643_bib0041","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.3390\/ijms26157301","article-title":"Breaking barriers: the role of the bone marrow microenvironment in multiple myeloma progression","volume":"26","author":"Agafonova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2025.102643_bib0042","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.3390\/jcm14196710","article-title":"The impact of endothelial cell values in bone marrow on the survival of patients with multiple myeloma-A single-center observational study","volume":"14","author":"Gawro\u0144ski","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tranon.2025.102643_bib0043","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1007\/s11033-019-04898-1","article-title":"Addressing the impact of different fetal bovine serum percentages on mesenchymal stem cells biological performance","volume":"46","author":"Khasawneh","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tranon.2025.102643_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272449","article-title":"Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro","volume":"17","author":"Khajah","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.tranon.2025.102643_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.584232","article-title":"HS-5 and HS-27A stromal cell lines to study bone marrow mesenchymal stromal cell-mediated support to cancer development","volume":"8","author":"Adamo","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tranon.2025.102643_bib0046","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0301-472X(01)00612-9","article-title":"Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)","volume":"29","author":"Garrido","year":"2001","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.tranon.2025.102643_bib0047","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3324\/haematol.2009.010736","article-title":"Hematopoietic stem cells in co-culture with mesenchymal stromal cells\u2013modeling the niche compartments in vitro","volume":"95","author":"Jing","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.tranon.2025.102643_bib0048","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.2147\/IJN.S184262","article-title":"Liposomal drug delivery in an in vitro 3D bone marrow model for multiple myeloma","volume":"13","author":"Braham","year":"2018","journal-title":"Int. J. Nanomedicine"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:58:02Z","timestamp":1781179082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325003742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":48,"alternative-id":["S1936523325003742"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102643","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BioMarrow: An accessible and reproducible 3D patient-derived bone marrow model for advancing research and clinical applications","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102643"}}